Skip to main content
Fig. 6 | Journal of Biomedical Science

Fig. 6

From: A novel mucosal bivalent vaccine of EV-A71/EV-D68 adjuvanted with polysaccharides from Ganoderma lucidum protects mice against EV-A71 and EV-D68 lethal challenge

Fig. 6

Effect of the EV-A71 + EV-D68 bivalent vaccine with or without PS-G or CpG as adjuvant on the levels of EV-D68- and EV-A71-specific IgG and IgA, and neutralization titre against infection by different enteroviruses in the sera of mice. The levels of a EV-D68-specific IgG and IgA and b EV-A71-specific IgG and IgA in the sera of mice after the third intranasal immunization were measured using ELISA. Sera were serially diluted (23–212), mixed with c EV-D68 and d EV-A71 virus, and used to infect RD cells. After 4 d, the highest dilution that resulted in the virus producing no cytopathic effect was considered to be the neutralization titre. All data are expressed as the mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page